Substituted oxindoles
US5502072A · kind A · utility
8Cited by
3References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 26, 1993 |
| Grant date | Mar 26, 1996 |
| Priority date | — |
| Expiry date | Nov 26, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel substituted oxindoles of the formula I as defined below and related compounds, pharmaceutical compositions comprising such compounds, and the use of such compounds as inhibitors of phosphodiesterase ("PDE") type IV. The compounds of this invention are useful in the treatment of AIDS, asthma, rheumatoid arthritis, osteoarthritis, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, atopic, dermatitis, shock, other inflammatory diseases, and other conditions where the action of phosphodiesterase type IV is implicated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.